Compare EMPD & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EMPD | RPID |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | United States |
| Employees | 15 | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.2M | 102.6M |
| IPO Year | N/A | 2021 |
| Metric | EMPD | RPID |
|---|---|---|
| Price | $3.31 | $2.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 527.2K | 241.6K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $33,587,000.00 |
| Revenue This Year | $23.49 | $19.12 |
| Revenue Next Year | N/A | $18.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $3.19 | $1.66 |
| 52 Week High | $11.37 | $4.94 |
| Indicator | EMPD | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 41.19 | 53.24 |
| Support Level | $3.19 | $1.98 |
| Resistance Level | $4.98 | $2.17 |
| Average True Range (ATR) | 0.21 | 0.15 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 21.74 | 53.57 |
Empery Digital Inc is an all-electric, off-road powersports vehicle company developing and building electric two and four-wheel motorcycles and utility terrain vehicles, also known as side-by-sides, along with a complete line of upgrades and accessories. The company's products include motorcycle and UTV products that are all-electric and designed for off-road use.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.